Cytotoxic Lymphocyte Maturation Factor (interleukin 12) is a Synergistic Growth Factor for Hematopoietic Stem Cells
Overview
General Medicine
Authors
Affiliations
The recently cloned cytotoxic lymphocyte maturation factor (interleukin 12 [IL-12]) has been described as a growth factor for mature lymphocytes. The present study investigated whether purified recombinant murine IL-12 (rMuIL-12) also could affect the proliferation of primitive bone marrow progenitor cells. Using a population of Lin-Sca-1+ murine bone marrow stem cells, we now demonstrate that IL-12 is a potent synergistic factor for primitive hematopoietic stem cells. The synergy of IL-12 was observed in single-cell cloning assays, demonstrating that its effects are directly mediated. Specifically, IL-12 enhanced stem cell factor-induced myelopoiesis of Lin-Sca-1+ cells sevenfold, and synergized with colony-stimulating factors (CSFs) to induce proliferation of Lin-Sca-1+ stem cells. IL-12 increased the number of responding progenitor cells as well as the size of the colonies formed. IL-12 also increased colony formation of high proliferative potential colony-forming cells with multiple CSF combinations. The effects of IL-12 were concentration dependent with a 50% effective dose of 2-20 and 20-200 ng/ml, resulting in maximum stimulation. Furthermore, a neutralizing anti-IL-12 antibody blocked the synergistic effects of rMuIL-12. In addition, IL-12 was found to have synergistic effects on more committed bone marrow progenitors as well. Our results therefore suggest that in addition to being a potent lymphopoietic stimulator, IL-12 is a regulator of the growth of hematopoietic stem cells and their myeloid progeny.
Retinal ganglion cells induce stem cell-derived neuroprotection via IL-12 to SCGF-β crosstalk.
Xia Q, Chang K, Sun Y, Nahmou M, Noro T, Cheng Y Stem Cell Res Ther. 2025; 16(1):90.
PMID: 40001251 PMC: 11863831. DOI: 10.1186/s13287-025-04198-5.
Udenze D, Trus I, Lipsit S, Napper S, Karniychuk U Emerg Microbes Infect. 2022; 12(1):2147021.
PMID: 36369716 PMC: 9869997. DOI: 10.1080/22221751.2022.2147021.
Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells.
Zhang S, Morita M, Wang Z, Ooehara J, Zhang S, Xie M Blood Sci. 2022; 1(1):92-101.
PMID: 35402790 PMC: 8974953. DOI: 10.1097/BS9.0000000000000002.
Ramirez R, Herrera A, Ramirez J, Qian C, Melton D, Shireman P BMC Bioinformatics. 2019; 20(1):725.
PMID: 31852428 PMC: 6921543. DOI: 10.1186/s12859-019-3304-5.
Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects.
Gokhale M, Vainstein V, Tom J, Thomas S, Lawrence C, Gluzman-Poltorak Z Exp Hematol Oncol. 2014; 3(1):11.
PMID: 24725395 PMC: 3991894. DOI: 10.1186/2162-3619-3-11.